ERIC C. HSU - 31 Aug 2023 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
Sr. VP, Pre-Clinical Res/Dev
Signature
/s/ Eric A. Adams, attorney-in-fact for Mr. Eric C. Hsu
Issuer symbol
INM
Transactions as of
31 Aug 2023
Net transactions value
$0
Form type
4
Filing time
31 Aug 2023, 17:22:15 UTC
Previous filing
16 May 2023
Next filing
26 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Expiration) Expiration (or cancellation) of long derivative position with value received $0 -327 -4% $0.000000 7,854 31 Aug 2023 Common shares 327 $499.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Converted from the Canadian dollar exercise price of C$676.50 using an exchange rate of C$1.3531 = $US1.00